Quarterly report pursuant to Section 13 or 15(d)

DISCONTINUED OPERATIONS (Tables)

v3.24.3
DISCONTINUED OPERATIONS (Tables)
 9 Months Ended
Sep. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]  
SCHEDULE OF COMPONENTS OF ASSETS AND LIABILITIES AND REVENUE CLASSIFIED AS DISCONTINUED

The table below presents the significant components of its former Pharma Solutions business unit’s results included within loss from discontinued operations, net of tax in the condensed consolidated statements of operations for the three- and nine months ended September 30, 2024 and 2023.

 

                         
    For The Three Months Ended     For The Nine Months Ended  
    September 30,     September 30,  
    2024     2023     2024     2023  
                         
Revenue, net   $ -     $ -     $ -     $ -  
                                 
Loss from discontinued operations     -       -       -       (137 )
Income tax expense     82       86       260       248  
Loss from discontinued operations, net of tax   $ (82 )   $ (86 )   $ (260 )   $ (385 )